Henan Sainote Biotechnology Co., Ltd.

INNOVATION FOR PATHOLOGY DIAGNOSIS

+86-37156596939

[email protected]

English
Home Service & Support Primary Antibody IFU-part II

Primary Antibody IFU-part II

2022-05-25

By snt_manager

    Share to:

Alpha-1-Fetoprotein -Instruction for use

ARID1A-Instruction for use

Bcl-2 -Instruction for use

Bcl-6-Instruction for use

BRAF V600E-Instruction for use

CA125-Instruction for use

CAIX-Instruction for use

CD2-Instruction for use

CD2LFA-2-Instruction for use

CD3-Instruction for use

CD5-Instruction for use

CD7-Instruction for use

CD10-Instruction for use

CD13-Instruction for use

CD15 M-Instruction for use

CD15-Instruction for use

CD19-BT51E Instruction for use

CD19-EP169 Instruction for use

CD20-Instruction for use

CD21-Instruction for use

CD23-Instruction for use

CD30-Instruction for use

CD31-Instruction for use

CD34-Instruction for use

CD38-Instruction for use

CD45-Instruction for use

CD56-Instruction for use

CD61(Gpllla)-2f2 Instruction for use

CD68-Instruction for use

CD79a-Instruction for use

CD99-Instruction for use

CD117-Instruction for use

CD138-Instruction for use

CD138 M-Instruction for use

CDX-2-Instruction for use

E-Cadherin-EP6 Instruction for use

CK20-Instruction for use

c-MYC-Instruction for use

Cytokeratin (HMW)-Instruction for use

Cytokeratin 14-Instruction for use

Cytokeratin CAM5.2-Instruction for use

Cytokeratin Pan-Instruction for use

D2-40-Instruction for use

DPC4-Instruction for use

Prev:

Primary Antibody IFU-part III

Next:

Primary Antibody IFU-part I